0 CHECKOUT

PRODUCT FILTERS

REGION

65
14
12
10
10

COUNTRY

4
4
4
3
2

CATEGORIES

  • 27
  • 27
  • 21
  • 18
  • 17
  • 10
  • 10
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

54
62
78
174

PUBLISHED

1
14
60
174

PRODUCT TYPE

117
48
7
2

Search for: "Bayer: Performance, Products, Pipeline and Potential"

174 Products

Bayer Aspirin Protect-Drug Insights,2014

“Bayer Aspirin Protect - Drug Insights, 2014” provides Bayer Aspirin Protect marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

Published:  September 2015
Price:  From

Bayer HealthCare AG - Strategic SWOT Analysis Review

Bayer HealthCare AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

Published:  April 2015
Price:  From

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

Published:  August 2012
Price:  From

Pharmaceutical Products of the Future: 50-Company Pipeline Analysis to 2015

What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies...

Published:  July 2010
Price:  From

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

Published:  July 2015
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Bayer HealthCare Pharmaceuticals - Strategic SWOT Analysis Review

Bayer HealthCare Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

Published:  May 2015
Price:  From

Global Interferon Market & Pipeline Analysis 2015

Interferons are small, low molecular weight proteins of varying sizes induced during attack by infectious agents like viruses. Investigators have found that they are highly variable in nature and have...

Published:  April 2015
Price:  From

Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015

Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015 Summary This, ‘Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015’, provides an overview of the Deep Vein Thrombosis (DVT)’s therapeutic pipeline. This...

Published:  May 2015
Price:  From

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining...

Published:  July 2015
Price:  From

Bispecific Antibody Therapeutics Market (2nd Edition), 2014 - 2024

The concept of bispecific antibodies is increasingly gaining traction in the pharma industry owing to several therapeutic advantages and their potential to address challenges known with the monoclonal...

Published:  December 2014
Price:  From

Pulmonary Embolism - Pipeline Review, H1 2015

Pulmonary Embolism - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Embolism - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

Published:  November 2014
Price:  From

Venous (Vein) Thrombosis - Pipeline Review, H1 2015

Venous (Vein) Thrombosis - Pipeline Review, H1 2015 Summary This, ‘Venous (Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline. This...

Published:  April 2015
Price:  From

Venous Thromboembolism - Pipeline Review, H1 2015

Venous Thromboembolism - Pipeline Review, H1 2015 Summary This, ‘Venous Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Venous Thromboembolism’s therapeutic pipeline. This...

Published:  April 2015
Price:  From

Antibody Drug Conjugates: Contract Manufacturing Market, 2014 – 2024

The concept of Antibody drug conjugates (ADCs) is simple - a cytotoxic / chemotherapy drug is delivered to the target tissue through linking it with a monoclonal antibody. However, the practical challenge...

Published:  February 2014
Price:  From

Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables...

Published:  February 2015
Price:  From

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

Published:  August 2014
Price:  From

Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential

“Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential ” provides key data, information and analysis on the key lifecycle management strategies implemented by pharmaceutical...

Published:  February 2010
Price:  From

Animal Growth Promoters and Performance Enhancers Market by Segment (Antibiotics, Growth Hormones, Feed Enzymes, Organic Acids, Probiotics and Prebiotics, â-Agonists, Phytogenics), by Animals (Porcine, Poultry, Aquaculture) - Global Forecasts to 2018

The animal growth promoters and performance enhancers market is segmented into antibiotics/antimicrobials, probiotics and prebiotics, organic acids, feed enzymes, hormonal growth promonants, ß-agonists,...

Published:  April 2014
Price:  From
Loading Indicator

Our Clients

  • Walgreen's Company
  • Elanco Global
  • Nu Skin Enterprises
  • Kemin Industries, Inc.
  • Suan Farma Inc.
  • Metagenics, Inc.